JP2019506382A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506382A5
JP2019506382A5 JP2018536167A JP2018536167A JP2019506382A5 JP 2019506382 A5 JP2019506382 A5 JP 2019506382A5 JP 2018536167 A JP2018536167 A JP 2018536167A JP 2018536167 A JP2018536167 A JP 2018536167A JP 2019506382 A5 JP2019506382 A5 JP 2019506382A5
Authority
JP
Japan
Prior art keywords
cancer
tautomer
stereoisomer
enantiomer
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018536167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019506382A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/013253 external-priority patent/WO2017123809A1/en
Publication of JP2019506382A publication Critical patent/JP2019506382A/ja
Publication of JP2019506382A5 publication Critical patent/JP2019506382A5/ja
Pending legal-status Critical Current

Links

JP2018536167A 2016-01-12 2017-01-12 癌及びウイルスを阻害するための化合物 Pending JP2019506382A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662277653P 2016-01-12 2016-01-12
US62/277,653 2016-01-12
PCT/US2017/013253 WO2017123809A1 (en) 2016-01-12 2017-01-12 Compounds for inhibiting cancer and virus

Publications (2)

Publication Number Publication Date
JP2019506382A JP2019506382A (ja) 2019-03-07
JP2019506382A5 true JP2019506382A5 (enrdf_load_stackoverflow) 2020-03-05

Family

ID=59311465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018536167A Pending JP2019506382A (ja) 2016-01-12 2017-01-12 癌及びウイルスを阻害するための化合物

Country Status (7)

Country Link
US (1) US10745433B2 (enrdf_load_stackoverflow)
EP (1) EP3402800A4 (enrdf_load_stackoverflow)
JP (1) JP2019506382A (enrdf_load_stackoverflow)
CN (1) CN108884123A (enrdf_load_stackoverflow)
CA (1) CA3011289A1 (enrdf_load_stackoverflow)
TW (1) TWI638825B (enrdf_load_stackoverflow)
WO (1) WO2017123809A1 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11491123B2 (en) * 2016-06-23 2022-11-08 Health Research, Inc. Pharmaceutical compositions with antiflaviviral activity
US11384114B2 (en) 2016-12-09 2022-07-12 Warsaw Orthopedic, Inc. Polymorphic forms of an oxysterol and methods of making them
CN111518147A (zh) * 2020-04-29 2020-08-11 华东理工大学 苯甲酰苯胺类化合物及在制备铜绿假单胞菌抑制剂的增敏剂中的应用
US11767303B2 (en) 2020-07-24 2023-09-26 Health Research, Inc. Compounds and methods for inhibiting viral replication and methods of treating and preventing flaviviral infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE150471C (enrdf_load_stackoverflow) *
DD150471A1 (de) * 1979-07-02 1981-09-02 Konrad Schwabe Verfahren zur herstellung von 5-bromsalizyl-4'-chloranilid-0-glykosiden
US6555519B2 (en) 2000-03-30 2003-04-29 Bristol-Myers Squibb Company O-glucosylated benzamide SGLT2 inhibitors and method
CA2488363C (en) * 2002-06-06 2011-01-04 Institute Of Medicinal Molecular Design, Inc. O-substituted hydroxyaryl derivatives
AU2003249244A1 (en) * 2002-07-15 2004-02-02 Combinatorx, Incorporated Methods for the treatment of neoplasms
TW200529812A (en) * 2003-12-26 2005-09-16 Chugai Pharmaceutical Co Ltd Benzamide derivatives
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
US8211882B2 (en) 2008-03-08 2012-07-03 Richard Delarey Wood Glutamate receptor modulators and therapeutic agents
EP2699319B1 (en) 2011-04-18 2017-08-09 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft Niclosamide for the treatment of cancer metastasis
WO2014023329A1 (en) 2012-08-06 2014-02-13 Life And Brain Gmbh Niclosamide and its derivatives for use in the treatment of solid tumors
WO2014113467A1 (en) * 2013-01-15 2014-07-24 Board Of Regents, The University Of Texas System Stat3 inhibitor
CN103130696B (zh) * 2013-03-21 2014-06-11 山东大学 邻氨基苯甲酰胺类化合物及其制备方法与应用
CN104771386A (zh) 2014-01-10 2015-07-15 中国科学院广州生物医药与健康研究院 苯甲酰胺类化合物及其应用

Similar Documents

Publication Publication Date Title
JP2019506382A5 (enrdf_load_stackoverflow)
JP2010523670A5 (enrdf_load_stackoverflow)
JP2017511311A5 (enrdf_load_stackoverflow)
JP2017095457A5 (enrdf_load_stackoverflow)
CN107548391A (zh) 嘧啶或吡啶类化合物、其制备方法和医药用途
JP2011500713A5 (enrdf_load_stackoverflow)
JP2010501572A5 (enrdf_load_stackoverflow)
PH12017501989B1 (en) Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with pi3 kinases, containing same as active ingredient
JP2013522292A5 (enrdf_load_stackoverflow)
JP2019501204A5 (enrdf_load_stackoverflow)
JP2012153722A5 (enrdf_load_stackoverflow)
ME00937B (me) Kombinovane terapije koje sadrže hinoksalinske inhibitore pi3k-alfa za upotrebu u liječenju kancera
JP2016519062A5 (enrdf_load_stackoverflow)
JP2011522889A5 (enrdf_load_stackoverflow)
RU2015126856A (ru) Дисульфидные маскированные пролекарственные композиции и способы
JP2013166763A5 (enrdf_load_stackoverflow)
JP2016503799A5 (enrdf_load_stackoverflow)
JP2017510661A5 (enrdf_load_stackoverflow)
JP2017509586A5 (enrdf_load_stackoverflow)
JP2017526662A5 (enrdf_load_stackoverflow)
JP2017524013A5 (enrdf_load_stackoverflow)
JP2013502441A5 (enrdf_load_stackoverflow)
JP2017507175A5 (enrdf_load_stackoverflow)
JP2019529435A5 (enrdf_load_stackoverflow)
JP2018511643A5 (enrdf_load_stackoverflow)